 | • レポートコード：GIR-23F3805 • 出版社/出版日：GlobalInfoResearch / 2023年2月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、92ページ • 納品方法：Eメール（2~3営業日） • 産業分類：医薬品 |
| Single User | ￥504,600 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥756,900 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,009,200 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 「Global Epidermal Growth Factor (EGF) Market」レポートは、世界の市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供します。 グローバルインフォリサーチ社（香港）の最新の調査によると、世界の上皮成長因子（EGF）の市場規模は2021年のxxx米ドルから2028年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。 上皮成長因子（EGF）市場はタイプ（種類）とアプリケーション（用途）によって区分されます。2017年～2028年において、量と金額の観点からタイプ別およびアプリケーション別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。 タイプ別セグメントは次を対象にします。 ・液体式、粉末式 アプリケーション別セグメントは次のように区分されます。 ・EGFクリーム、EGFローション、EGFマスク、その他 世界の上皮成長因子（EGF）市場の主要なマーケットプレーヤーは以下のとおりです。 ・Pavay、Radiant、BIO-FDandC、LipoTrue、BIOEFFECT 地域別セグメントは次の地域・国を対象にします。 ・北米市場（米国、カナダ、メキシコ） ・ヨーロッパ市場（ドイツ、フランス、イギリス、ロシア、イタリア） ・アジア太平洋市場（日本、中国、韓国、インド、東南アジア、オーストラリア） ・南米市場（ブラジル、アルゼンチン、コロンビア） ・中東・アフリカ市場（サウジアラビア、UAE、エジプト、南アフリカ） ***** 目次(一部) ***** ・市場概要 - 上皮成長因子（EGF）の概要 - タイプ別分析（2017年vs2021年vs2028年）：液体式、粉末式 - アプリケーション別分析（2017年vs2021年vs2028年）：EGFクリーム、EGFローション、EGFマスク、その他 - 世界の上皮成長因子（EGF）市場規模・予測 - 世界の上皮成長因子（EGF）生産能力分析 - 市場の成長要因・阻害要因・動向 ・メーカー情報（企業概要、製品概要、販売量、価格、売上） - Pavay、Radiant、BIO-FDandC、LipoTrue、BIOEFFECT ・メーカー別市場シェア・市場集中度 ・地域別市場分析2017年-2028年 ・タイプ別分析2017年-2028年：液体式、粉末式 ・アプリケーション別分析2017年-2028年：EGFクリーム、EGFローション、EGFマスク、その他 ・上皮成長因子（EGF）の北米市場分析 - 上皮成長因子（EGF）の北米市場：タイプ別市場規模2017年-2028年 - 上皮成長因子（EGF）の北米市場：アプリケーション別市場規模2017年-2028年 - 主要国別市場規模：アメリカ、カナダ、メキシコなど ・上皮成長因子（EGF）のヨーロッパ市場分析 - ：上皮成長因子（EGF）のヨーロッパ市場：タイプ別市場規模2017年-2028年 - ：上皮成長因子（EGF）のヨーロッパ市場：アプリケーション別市場規模2017年-2028年 - 主要国別市場規模：ドイツ、イギリス、フランス、ロシア、イタリアなど ・上皮成長因子（EGF）のアジア太平洋市場分析 - 上皮成長因子（EGF）のアジア太平洋市場：タイプ別市場規模2017年-2028年 - 上皮成長因子（EGF）のアジア太平洋市場：アプリケーション別市場規模2017年-2028年 - 主要国別市場規模：中国、日本、韓国、インド、東南アジア、オーストラリアなど ・上皮成長因子（EGF）の南米市場分析 - 上皮成長因子（EGF）の南米市場：タイプ別市場規模2017年-2028年 - 上皮成長因子（EGF）の南米市場：アプリケーション別市場規模2017年-2028年 - 主要国別市場規模：ブラジル、アルゼンチンなど ・上皮成長因子（EGF）の中東・アフリカ市場分析 - 上皮成長因子（EGF）の中東・アフリカ市場：タイプ別市場規模2017年-2028年 - 上皮成長因子（EGF）の中東・アフリカ市場：アプリケーション別市場規模2017年-2028年 - 主要国別市場規模：サウジアラビア、トルコ、エジプト、南アフリカなど ・原材料および産業チェーン ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Epidermal Growth Factor (EGF) market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Epidermal Growth Factor (EGF) market size is estimated to be worth US$ 139.5 million in 2021 and is forecast to a readjusted size of USD 202.4 million by 2028 with a CAGR of 5.5% during review period. EGF Cream accounting for % of the Epidermal Growth Factor (EGF) global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Liquid segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Epidermal Growth Factor (EGF) include Pavay, Radiant, BIO-FDandC, LipoTrue, and BIOEFFECT, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Epidermal Growth Factor (EGF) market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Liquid
Powder
Market segment by Application can be divided into
EGF Cream
EGF Lotion
EGF Mask
Other
The key market players for global Epidermal Growth Factor (EGF) market are listed below:
Pavay
Radiant
BIO-FDandC
LipoTrue
BIOEFFECT
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Epidermal Growth Factor (EGF) product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Epidermal Growth Factor (EGF), with price, sales, revenue and global market share of Epidermal Growth Factor (EGF) from 2019 to 2022.
Chapter 3, the Epidermal Growth Factor (EGF) competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Epidermal Growth Factor (EGF) breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Epidermal Growth Factor (EGF) market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Epidermal Growth Factor (EGF).
Chapter 13, 14, and 15, to describe Epidermal Growth Factor (EGF) sales channel, distributors, customers, research findings and conclusion, appendix and data source.
1 Market Overview
1.1 Epidermal Growth Factor (EGF) Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Epidermal Growth Factor (EGF) Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 Liquid
1.2.3 Powder
1.3 Market Analysis by Application
1.3.1 Overview: Global Epidermal Growth Factor (EGF) Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 EGF Cream
1.3.3 EGF Lotion
1.3.4 EGF Mask
1.3.5 Other
1.4 Global Epidermal Growth Factor (EGF) Market Size & Forecast
1.4.1 Global Epidermal Growth Factor (EGF) Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Epidermal Growth Factor (EGF) Sales in Volume (2017-2028)
1.4.3 Global Epidermal Growth Factor (EGF) Price (2017-2028)
1.5 Global Epidermal Growth Factor (EGF) Production Capacity Analysis
1.5.1 Global Epidermal Growth Factor (EGF) Total Production Capacity (2017-2028)
1.5.2 Global Epidermal Growth Factor (EGF) Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Epidermal Growth Factor (EGF) Market Drivers
1.6.2 Epidermal Growth Factor (EGF) Market Restraints
1.6.3 Epidermal Growth Factor (EGF) Trends Analysis
2 Manufacturers Profiles
2.1 Pavay
2.1.1 Pavay Details
2.1.2 Pavay Major Business
2.1.3 Pavay Epidermal Growth Factor (EGF) Product and Services
2.1.4 Pavay Epidermal Growth Factor (EGF) Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 Radiant
2.2.1 Radiant Details
2.2.2 Radiant Major Business
2.2.3 Radiant Epidermal Growth Factor (EGF) Product and Services
2.2.4 Radiant Epidermal Growth Factor (EGF) Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 BIO-FDandC
2.3.1 BIO-FDandC Details
2.3.2 BIO-FDandC Major Business
2.3.3 BIO-FDandC Epidermal Growth Factor (EGF) Product and Services
2.3.4 BIO-FDandC Epidermal Growth Factor (EGF) Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 LipoTrue
2.4.1 LipoTrue Details
2.4.2 LipoTrue Major Business
2.4.3 LipoTrue Epidermal Growth Factor (EGF) Product and Services
2.4.4 LipoTrue Epidermal Growth Factor (EGF) Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 BIOEFFECT
2.5.1 BIOEFFECT Details
2.5.2 BIOEFFECT Major Business
2.5.3 BIOEFFECT Epidermal Growth Factor (EGF) Product and Services
2.5.4 BIOEFFECT Epidermal Growth Factor (EGF) Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Epidermal Growth Factor (EGF) Breakdown Data by Manufacturer
3.1 Global Epidermal Growth Factor (EGF) Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Epidermal Growth Factor (EGF) Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Epidermal Growth Factor (EGF)
3.4 Market Concentration Rate
3.4.1 Top 3 Epidermal Growth Factor (EGF) Manufacturer Market Share in 2021
3.4.2 Top 6 Epidermal Growth Factor (EGF) Manufacturer Market Share in 2021
3.5 Global Epidermal Growth Factor (EGF) Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Epidermal Growth Factor (EGF) Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Epidermal Growth Factor (EGF) Market Size by Region
4.1.1 Global Epidermal Growth Factor (EGF) Sales in Volume by Region (2017-2028)
4.1.2 Global Epidermal Growth Factor (EGF) Revenue by Region (2017-2028)
4.2 North America Epidermal Growth Factor (EGF) Revenue (2017-2028)
4.3 Europe Epidermal Growth Factor (EGF) Revenue (2017-2028)
4.4 Asia-Pacific Epidermal Growth Factor (EGF) Revenue (2017-2028)
4.5 South America Epidermal Growth Factor (EGF) Revenue (2017-2028)
4.6 Middle East and Africa Epidermal Growth Factor (EGF) Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Epidermal Growth Factor (EGF) Sales in Volume by Type (2017-2028)
5.2 Global Epidermal Growth Factor (EGF) Revenue by Type (2017-2028)
5.3 Global Epidermal Growth Factor (EGF) Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Epidermal Growth Factor (EGF) Sales in Volume by Application (2017-2028)
6.2 Global Epidermal Growth Factor (EGF) Revenue by Application (2017-2028)
6.3 Global Epidermal Growth Factor (EGF) Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Epidermal Growth Factor (EGF) Sales by Type (2017-2028)
7.2 North America Epidermal Growth Factor (EGF) Sales by Application (2017-2028)
7.3 North America Epidermal Growth Factor (EGF) Market Size by Country
7.3.1 North America Epidermal Growth Factor (EGF) Sales in Volume by Country (2017-2028)
7.3.2 North America Epidermal Growth Factor (EGF) Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Epidermal Growth Factor (EGF) Sales by Type (2017-2028)
8.2 Europe Epidermal Growth Factor (EGF) Sales by Application (2017-2028)
8.3 Europe Epidermal Growth Factor (EGF) Market Size by Country
8.3.1 Europe Epidermal Growth Factor (EGF) Sales in Volume by Country (2017-2028)
8.3.2 Europe Epidermal Growth Factor (EGF) Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Epidermal Growth Factor (EGF) Sales by Type (2017-2028)
9.2 Asia-Pacific Epidermal Growth Factor (EGF) Sales by Application (2017-2028)
9.3 Asia-Pacific Epidermal Growth Factor (EGF) Market Size by Region
9.3.1 Asia-Pacific Epidermal Growth Factor (EGF) Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Epidermal Growth Factor (EGF) Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Epidermal Growth Factor (EGF) Sales by Type (2017-2028)
10.2 South America Epidermal Growth Factor (EGF) Sales by Application (2017-2028)
10.3 South America Epidermal Growth Factor (EGF) Market Size by Country
10.3.1 South America Epidermal Growth Factor (EGF) Sales in Volume by Country (2017-2028)
10.3.2 South America Epidermal Growth Factor (EGF) Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Epidermal Growth Factor (EGF) Sales by Type (2017-2028)
11.2 Middle East & Africa Epidermal Growth Factor (EGF) Sales by Application (2017-2028)
11.3 Middle East & Africa Epidermal Growth Factor (EGF) Market Size by Country
11.3.1 Middle East & Africa Epidermal Growth Factor (EGF) Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Epidermal Growth Factor (EGF) Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Epidermal Growth Factor (EGF) and Key Manufacturers
12.2 Manufacturing Costs Percentage of Epidermal Growth Factor (EGF)
12.3 Epidermal Growth Factor (EGF) Production Process
12.4 Epidermal Growth Factor (EGF) Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Epidermal Growth Factor (EGF) Typical Distributors
13.3 Epidermal Growth Factor (EGF) Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer
Table 1. Global Epidermal Growth Factor (EGF) Revenue by Type, (USD Million), 2017 & 2021 & 2028
Table 2. Global Epidermal Growth Factor (EGF) Revenue by Application, (USD Million), 2017 & 2021 & 2028
Table 3. Pavay Basic Information, Manufacturing Base and Competitors
Table 4. Pavay Major Business
Table 5. Pavay Epidermal Growth Factor (EGF) Product and Services
Table 6. Pavay Epidermal Growth Factor (EGF) Sales (g), Price (USD/g), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 7. Radiant Basic Information, Manufacturing Base and Competitors
Table 8. Radiant Major Business
Table 9. Radiant Epidermal Growth Factor (EGF) Product and Services
Table 10. Radiant Epidermal Growth Factor (EGF) Sales (g), Price (USD/g), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 11. BIO-FDandC Basic Information, Manufacturing Base and Competitors
Table 12. BIO-FDandC Major Business
Table 13. BIO-FDandC Epidermal Growth Factor (EGF) Product and Services
Table 14. BIO-FDandC Epidermal Growth Factor (EGF) Sales (g), Price (USD/g), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 15. LipoTrue Basic Information, Manufacturing Base and Competitors
Table 16. LipoTrue Major Business
Table 17. LipoTrue Epidermal Growth Factor (EGF) Product and Services
Table 18. LipoTrue Epidermal Growth Factor (EGF) Sales (g), Price (USD/g), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 19. BIOEFFECT Basic Information, Manufacturing Base and Competitors
Table 20. BIOEFFECT Major Business
Table 21. BIOEFFECT Epidermal Growth Factor (EGF) Product and Services
Table 22. BIOEFFECT Epidermal Growth Factor (EGF) Sales (g), Price (USD/g), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 23. Global Epidermal Growth Factor (EGF) Sales by Manufacturer (2019, 2020, 2021, and 2022) & (g)
Table 24. Global Epidermal Growth Factor (EGF) Revenue by Manufacturer (2019, 2020, 2021, and 2022) & (USD Million)
Table 25. Market Position of Manufacturers in Epidermal Growth Factor (EGF), (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2021
Table 26. Global Epidermal Growth Factor (EGF) Production Capacity by Company, (g): 2020 VS 2021
Table 27. Head Office and Epidermal Growth Factor (EGF) Production Site of Key Manufacturer
Table 28. Epidermal Growth Factor (EGF) New Entrant and Capacity Expansion Plans
Table 29. Epidermal Growth Factor (EGF) Mergers & Acquisitions in the Past Five Years
Table 30. Global Epidermal Growth Factor (EGF) Sales by Region (2017-2022) & (g)
Table 31. Global Epidermal Growth Factor (EGF) Sales by Region (2023-2028) & (g)
Table 32. Global Epidermal Growth Factor (EGF) Revenue by Region (2017-2022) & (USD Million)
Table 33. Global Epidermal Growth Factor (EGF) Revenue by Region (2023-2028) & (USD Million)
Table 34. Global Epidermal Growth Factor (EGF) Sales by Type (2017-2022) & (g)
Table 35. Global Epidermal Growth Factor (EGF) Sales by Type (2023-2028) & (g)
Table 36. Global Epidermal Growth Factor (EGF) Revenue by Type (2017-2022) & (USD Million)
Table 37. Global Epidermal Growth Factor (EGF) Revenue by Type (2023-2028) & (USD Million)
Table 38. Global Epidermal Growth Factor (EGF) Price by Type (2017-2022) & (USD/g)
Table 39. Global Epidermal Growth Factor (EGF) Price by Type (2023-2028) & (USD/g)
Table 40. Global Epidermal Growth Factor (EGF) Sales by Application (2017-2022) & (g)
Table 41. Global Epidermal Growth Factor (EGF) Sales by Application (2023-2028) & (g)
Table 42. Global Epidermal Growth Factor (EGF) Revenue by Application (2017-2022) & (USD Million)
Table 43. Global Epidermal Growth Factor (EGF) Revenue by Application (2023-2028) & (USD Million)
Table 44. Global Epidermal Growth Factor (EGF) Price by Application (2017-2022) & (USD/g)
Table 45. Global Epidermal Growth Factor (EGF) Price by Application (2023-2028) & (USD/g)
Table 46. North America Epidermal Growth Factor (EGF) Sales by Country (2017-2022) & (g)
Table 47. North America Epidermal Growth Factor (EGF) Sales by Country (2023-2028) & (g)
Table 48. North America Epidermal Growth Factor (EGF) Revenue by Country (2017-2022) & (USD Million)
Table 49. North America Epidermal Growth Factor (EGF) Revenue by Country (2023-2028) & (USD Million)
Table 50. North America Epidermal Growth Factor (EGF) Sales by Type (2017-2022) & (g)
Table 51. North America Epidermal Growth Factor (EGF) Sales by Type (2023-2028) & (g)
Table 52. North America Epidermal Growth Factor (EGF) Sales by Application (2017-2022) & (g)
Table 53. North America Epidermal Growth Factor (EGF) Sales by Application (2023-2028) & (g)
Table 54. Europe Epidermal Growth Factor (EGF) Sales by Country (2017-2022) & (g)
Table 55. Europe Epidermal Growth Factor (EGF) Sales by Country (2023-2028) & (g)
Table 56. Europe Epidermal Growth Factor (EGF) Revenue by Country (2017-2022) & (USD Million)
Table 57. Europe Epidermal Growth Factor (EGF) Revenue by Country (2023-2028) & (USD Million)
Table 58. Europe Epidermal Growth Factor (EGF) Sales by Type (2017-2022) & (g)
Table 59. Europe Epidermal Growth Factor (EGF) Sales by Type (2023-2028) & (g)
Table 60. Europe Epidermal Growth Factor (EGF) Sales by Application (2017-2022) & (g)
Table 61. Europe Epidermal Growth Factor (EGF) Sales by Application (2023-2028) & (g)
Table 62. Asia-Pacific Epidermal Growth Factor (EGF) Sales by Region (2017-2022) & (g)
Table 63. Asia-Pacific Epidermal Growth Factor (EGF) Sales by Region (2023-2028) & (g)
Table 64. Asia-Pacific Epidermal Growth Factor (EGF) Revenue by Region (2017-2022) & (USD Million)
Table 65. Asia-Pacific Epidermal Growth Factor (EGF) Revenue by Region (2023-2028) & (USD Million)
Table 66. Asia-Pacific Epidermal Growth Factor (EGF) Sales by Type (2017-2022) & (g)
Table 67. Asia-Pacific Epidermal Growth Factor (EGF) Sales by Type (2023-2028) & (g)
Table 68. Asia-Pacific Epidermal Growth Factor (EGF) Sales by Application (2017-2022) & (g)
Table 69. Asia-Pacific Epidermal Growth Factor (EGF) Sales by Application (2023-2028) & (g)
Table 70. South America Epidermal Growth Factor (EGF) Sales by Country (2017-2022) & (g)
Table 71. South America Epidermal Growth Factor (EGF) Sales by Country (2023-2028) & (g)
Table 72. South America Epidermal Growth Factor (EGF) Revenue by Country (2017-2022) & (USD Million)
Table 73. South America Epidermal Growth Factor (EGF) Revenue by Country (2023-2028) & (USD Million)
Table 74. South America Epidermal Growth Factor (EGF) Sales by Type (2017-2022) & (g)
Table 75. South America Epidermal Growth Factor (EGF) Sales by Type (2023-2028) & (g)
Table 76. South America Epidermal Growth Factor (EGF) Sales by Application (2017-2022) & (g)
Table 77. South America Epidermal Growth Factor (EGF) Sales by Application (2023-2028) & (g)
Table 78. Middle East & Africa Epidermal Growth Factor (EGF) Sales by Region (2017-2022) & (g)
Table 79. Middle East & Africa Epidermal Growth Factor (EGF) Sales by Region (2023-2028) & (g)
Table 80. Middle East & Africa Epidermal Growth Factor (EGF) Revenue by Region (2017-2022) & (USD Million)
Table 81. Middle East & Africa Epidermal Growth Factor (EGF) Revenue by Region (2023-2028) & (USD Million)
Table 82. Middle East & Africa Epidermal Growth Factor (EGF) Sales by Type (2017-2022) & (g)
Table 83. Middle East & Africa Epidermal Growth Factor (EGF) Sales by Type (2023-2028) & (g)
Table 84. Middle East & Africa Epidermal Growth Factor (EGF) Sales by Application (2017-2022) & (g)
Table 85. Middle East & Africa Epidermal Growth Factor (EGF) Sales by Application (2023-2028) & (g)
Table 86. Epidermal Growth Factor (EGF) Raw Material
Table 87. Key Manufacturers of Epidermal Growth Factor (EGF) Raw Materials
Table 88. Direct Channel Pros & Cons
Table 89. Indirect Channel Pros & Cons
Table 90. Epidermal Growth Factor (EGF) Typical Distributors
Table 91. Epidermal Growth Factor (EGF) Typical Customers
List of Figures
Figure 1. Epidermal Growth Factor (EGF) Picture
Figure 2. Global Epidermal Growth Factor (EGF) Revenue Market Share by Type in 2021
Figure 3. Liquid
Figure 4. Powder
Figure 5. Global Epidermal Growth Factor (EGF) Revenue Market Share by Application in 2021
Figure 6. EGF Cream
Figure 7. EGF Lotion
Figure 8. EGF Mask
Figure 9. Other
Figure 10. Global Epidermal Growth Factor (EGF) Revenue, (USD Million) & (g): 2017 & 2021 & 2028
Figure 11. Global Epidermal Growth Factor (EGF) Revenue and Forecast (2017-2028) & (USD Million)
Figure 12. Global Epidermal Growth Factor (EGF) Sales (2017-2028) & (g)
Figure 13. Global Epidermal Growth Factor (EGF) Price (2017-2028) & (USD/g)
Figure 14. Global Epidermal Growth Factor (EGF) Production Capacity (2017-2028) & (g)
Figure 15. Global Epidermal Growth Factor (EGF) Production Capacity by Geographic Region: 2022 VS 2028
Figure 16. Epidermal Growth Factor (EGF) Market Drivers
Figure 17. Epidermal Growth Factor (EGF) Market Restraints
Figure 18. Epidermal Growth Factor (EGF) Market Trends
Figure 19. Global Epidermal Growth Factor (EGF) Sales Market Share by Manufacturer in 2021
Figure 20. Global Epidermal Growth Factor (EGF) Revenue Market Share by Manufacturer in 2021
Figure 21. Epidermal Growth Factor (EGF) Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2021
Figure 22. Top 3 Epidermal Growth Factor (EGF) Manufacturer (Revenue) Market Share in 2021
Figure 23. Top 6 Epidermal Growth Factor (EGF) Manufacturer (Revenue) Market Share in 2021
Figure 24. Global Epidermal Growth Factor (EGF) Sales Market Share by Region (2017-2028)
Figure 25. Global Epidermal Growth Factor (EGF) Revenue Market Share by Region (2017-2028)
Figure 26. North America Epidermal Growth Factor (EGF) Revenue (2017-2028) & (USD Million)
Figure 27. Europe Epidermal Growth Factor (EGF) Revenue (2017-2028) & (USD Million)
Figure 28. Asia-Pacific Epidermal Growth Factor (EGF) Revenue (2017-2028) & (USD Million)
Figure 29. South America Epidermal Growth Factor (EGF) Revenue (2017-2028) & (USD Million)
Figure 30. Middle East & Africa Epidermal Growth Factor (EGF) Revenue (2017-2028) & (USD Million)
Figure 31. Global Epidermal Growth Factor (EGF) Sales Market Share by Type (2017-2028)
Figure 32. Global Epidermal Growth Factor (EGF) Revenue Market Share by Type (2017-2028)
Figure 33. Global Epidermal Growth Factor (EGF) Price by Type (2017-2028) & (USD/g)
Figure 34. Global Epidermal Growth Factor (EGF) Sales Market Share by Application (2017-2028)
Figure 35. Global Epidermal Growth Factor (EGF) Revenue Market Share by Application (2017-2028)
Figure 36. Global Epidermal Growth Factor (EGF) Price by Application (2017-2028) & (USD/g)
Figure 37. North America Epidermal Growth Factor (EGF) Sales Market Share by Type (2017-2028)
Figure 38. North America Epidermal Growth Factor (EGF) Sales Market Share by Application (2017-2028)
Figure 39. North America Epidermal Growth Factor (EGF) Sales Market Share by Country (2017-2028)
Figure 40. North America Epidermal Growth Factor (EGF) Revenue Market Share by Country (2017-2028)
Figure 41. United States Epidermal Growth Factor (EGF) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 42. Canada Epidermal Growth Factor (EGF) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 43. Mexico Epidermal Growth Factor (EGF) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 44. Europe Epidermal Growth Factor (EGF) Sales Market Share by Type (2017-2028)
Figure 45. Europe Epidermal Growth Factor (EGF) Sales Market Share by Application (2017-2028)
Figure 46. Europe Epidermal Growth Factor (EGF) Sales Market Share by Country (2017-2028)
Figure 47. Europe Epidermal Growth Factor (EGF) Revenue Market Share by Country (2017-2028)
Figure 48. Germany Epidermal Growth Factor (EGF) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 49. France Epidermal Growth Factor (EGF) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 50. United Kingdom Epidermal Growth Factor (EGF) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 51. Russia Epidermal Growth Factor (EGF) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 52. Italy Epidermal Growth Factor (EGF) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 53. Asia-Pacific Epidermal Growth Factor (EGF) Sales Market Share by Region (2017-2028)
Figure 54. Asia-Pacific Epidermal Growth Factor (EGF) Sales Market Share by Application (2017-2028)
Figure 55. Asia-Pacific Epidermal Growth Factor (EGF) Sales Market Share by Region (2017-2028)
Figure 56. Asia-Pacific Epidermal Growth Factor (EGF) Revenue Market Share by Region (2017-2028)
Figure 57. China Epidermal Growth Factor (EGF) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 58. Japan Epidermal Growth Factor (EGF) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 59. Korea Epidermal Growth Factor (EGF) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 60. India Epidermal Growth Factor (EGF) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. Southeast Asia Epidermal Growth Factor (EGF) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 62. Australia Epidermal Growth Factor (EGF) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 63. South America Epidermal Growth Factor (EGF) Sales Market Share by Type (2017-2028)
Figure 64. South America Epidermal Growth Factor (EGF) Sales Market Share by Application (2017-2028)
Figure 65. South America Epidermal Growth Factor (EGF) Sales Market Share by Country (2017-2028)
Figure 66. South America Epidermal Growth Factor (EGF) Revenue Market Share by Country (2017-2028)
Figure 67. Brazil Epidermal Growth Factor (EGF) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 68. Argentina Epidermal Growth Factor (EGF) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 69. Middle East & Africa Epidermal Growth Factor (EGF) Sales Market Share by Type (2017-2028)
Figure 70. Middle East & Africa Epidermal Growth Factor (EGF) Sales Market Share by Application (2017-2028)
Figure 71. Middle East & Africa Epidermal Growth Factor (EGF) Sales Market Share by Region (2017-2028)
Figure 72. Middle East & Africa Epidermal Growth Factor (EGF) Revenue Market Share by Region (2017-2028)
Figure 73. Turkey Epidermal Growth Factor (EGF) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 74. Egypt Epidermal Growth Factor (EGF) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 75. Saudi Arabia Epidermal Growth Factor (EGF) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 76. South Africa Epidermal Growth Factor (EGF) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 77. Manufacturing Cost Structure Analysis of Epidermal Growth Factor (EGF) in 2021
Figure 78. Manufacturing Process Analysis of Epidermal Growth Factor (EGF)
Figure 79. Epidermal Growth Factor (EGF) Industrial Chain
Figure 80. Sales Channel: Direct Channel vs Indirect Channel
Figure 81. Methodology
Figure 82. Research Process and Data Source
| 【上皮成長因子（EGF）について】 上皮成長因子（EGF）は、生物学的な活性を持つペプチドであり、主に上皮細胞の増殖や分化を促進する物質として知られています。この因子は、1975年にアーサー・ロスとそのチームによって最初に発見され、その後様々な研究によってその重要性が明らかになりました。EGFは、特に細胞の成長や再生過程において中心的な役割を果たし、組織の修復や傷の治癒に寄与しています。 EGFの構造は、53アミノ酸からなる小さなペプチドであり、特定の細胞表面受容体に結合することによってその機能を発揮します。EGFは、EGF受容体（EGFR）と呼ばれる膜貫通型受容体に結合し、細胞内のシグナル伝達経路を活性化します。このシグナル伝達は細胞の増殖、移動、分化を促す一連の反応を引き起こし、最終的には生理学的な効果をもたらします。 EGFの主な特徴の一つは、その高い生理活性です。非常に低い濃度でも細胞に影響を与えることができ、特に皮膚やその他の上皮組織の再生過程において重要な役割を果たします。また、EGFはさまざまな種類の細胞に対して作用し、組織特異的な効果を持つことも特徴です。さらに、EGFは細胞の老化を抑制し、腫瘍細胞においては異常な増殖を促進する場合もあります。 EGFは、主に二つの種類に分類されます。第一の種類は、自然由来のEGFであり、唾液腺や腎臓、腸管など、いくつかの組織から分泌されます。第二の種類は、合成EGFであり、主にバイオテクノロジーによって生産されるものです。合成EGFは、細胞培養技術や遺伝子組換え技術を用いて、純度の高い形で取り出されます。これにより、大量生産が可能になり、研究や医療への応用が進んでいます。 EGFの主な用途としては、医療分野における皮膚の再生医療や創傷治癒、さらには美容分野におけるスキンケア製品での利用が挙げられます。例えば、EGFを含む化粧品は、肌の保湿や弾力性を向上させ、老化の兆候を抑える効果があるとされています。また、創傷治癒においては、EGFを直接傷口に適用することで、細胞の再生を促進し、傷が早く治るのを助けることが期待されます。 EGFの関連技術としては、遺伝子工学や培養細胞技術が重要です。バイオテクノロジーの進展により、EGFを基盤とした治療法や製品の開発が加速度的に進んでおり、再生医療やがん治療において新たな選択肢が提供されています。具体的には、EGFを利用した細胞治療や生体材料の開発が行われており、これにより組織の再生能力を高めることが狙われています。 EGFの研究は、腫瘍生物学においても重要な位置を占めています。EGF受容体（EGFR）の異常な活性化は、さまざまな癌の発生や進行に関与していることが知られており、これに対する治療薬の開発も進められています。EGFRを標的とした分子標的治療薬は、特に非小細胞肺癌などの治療において有望な成果を上げています。 さらに、EGFは創薬の分野でも重要なターゲットとなっています。EGFシグナル経路に関連する分子や因子は、癌細胞の増殖や浸潤に関与しているため、新たな治療戦略の開発に向けた研究が続けられています。新しいEGF関連の治療が成功すれば、これまで難治性とされていたがんやその他の疾患への新たなアプローチが期待できます。 EGFの利用や研究の拡大に伴い、その倫理的な側面や安全性についても議論が進んでいます。特に、EGFを含む医薬品や食品が市場に出る際には、厳しい規制や基準が設けられています。EGF治療の効果を最大限に引き出すためには、適切な投与量や投与方法、治療期間が重要です。また、副作用やアレルギー反応などのリスクに対する認識も欠かせません。 結論として、上皮成長因子は生物学的な重要性を持つペプチドとして、医療、特に再生医療や腫瘍治療において大きな可能性を秘めています。EGFに関する研究や技術の進展は、今後も新しい治療法の開発や医療の進歩に寄与することが期待されます。今後の研究によって、EGFのメカニズムや機能がさらに解明され、新たな医療応用が広がることを期待しています。 |